Gene Detection for Breast Cancer
Introduction
BRCA1/2 gene mutation is closely related to the risk of breast cancer

A large number of studies have shown that the occurrence, development and inheritance of breast cancer are closely related to BRCA1/2 gene mutations. Women with mutations in the BRCA1 and BRCA2 genes have a significantly increased lifetime risk of breast cancer and ovarian cancer.

High genetic risk

Breast cancer caused by BRCA1/2 gene mutation exhibits the tendency of familial inheritance. If one party of both parents carries gene mutation, the mutation is likely to transmit to the offspring at a probability of 50%.

Guideline recommendation

In view of the hazard caused by BRCA1/2 gene mutation, the National Comprehensive Cancer Network (NCCN) and the Breast Cancer Professional Committee of the Chinese Anti-Cancer Association have formulated targeted clinical practice guidelines, which include the BRCA1/2 gene detection standards, and emphasize the necessity of genetic screening for breast cancer.

Test items

The entire coding regions of the two genes, BRCA1 and BRCA2, totally about 16,000 sites.

Applicable
  • Family members of breast cancer/ovarian cancer patients, and other healthy population being concerned about their own breast health
  • Breast cancer/ovarian cancer patients